AstraZeneca to buy vaccine developer Icosavax for $1.1bn
Pharmaceutical company AstraZeneca said on Tuesday it had agreed to buy infectious disease vaccine developer Icosavax in a deal worth up to $1.1bn to support its respiratory syncytial virus vaccine.
POPULAR POSTS
IEA warns ‘electricity era’ will come after fossil fuels peak
October 17, 2024
Easter Island fights global plastic waste vortex
October 17, 2024
Egypt opens more galleries at its antiquities museum
October 17, 2024
LIVE STREAM